Stryker (NYSE:SYK) and Merit Medical Systems (NASDAQ:MMSI) Critical Comparison

Stryker (NYSE:SYK – Get Free Report) and Merit Medical Systems (NASDAQ:MMSI – Get Free Report) are both healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, institutional ownership, profitability, analyst recommendations, earnings, dividends and risk.

Earnings & Valuation

This table compares Stryker and Merit Medical Systems”s gross revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Stryker $26.30 billion 4.49 $3.25 billion $9.39 33.05
Merit Medical Systems $1.61 billion 3.21 $128.49 million $2.66 32.46

Stryker has higher revenue and earnings than Merit Medical Systems. Merit Medical Systems is trading at a lower price-to-earnings ratio than Stryker, indicating that it is currently the more affordable of the two stocks.

Volatility and Risk

Stryker has a beta of 0.78, indicating that its share price is 22% less volatile than the S&P 500. Comparatively, Merit Medical Systems has a beta of 0.56, indicating that its share price is 44% less volatile than the S&P 500.

Profitability

This table compares Stryker and Merit Medical Systems’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Stryker 13.78% 23.74% 11.64%
Merit Medical Systems 9.94% 14.12% 8.37%

Analyst Recommendations

This is a summary of current ratings and price targets for Stryker and Merit Medical Systems, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Stryker 0 7 21 0 2.75
Merit Medical Systems 0 5 8 0 2.62

Stryker presently has a consensus target price of $342.19, indicating a potential upside of 10.28%. Merit Medical Systems has a consensus target price of $105.91, indicating a potential upside of 22.65%. Given Merit Medical Systems’ higher probable upside, analysts plainly believe Merit Medical Systems is more favorable than Stryker.

Insider and Institutional Ownership

77.1% of Stryker shares are owned by institutional investors. Comparatively, 99.7% of Merit Medical Systems shares are owned by institutional investors. 4.6% of Stryker shares are owned by company insiders. Comparatively, 0.7% of Merit Medical Systems shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

Stryker beats Merit Medical Systems on 12 of the 14 factors compared between the two stocks.

About Stryker

(Get Free Report)

Stryker is a medical technology company that develops and sells products and services for healthcare providers. Its offerings include orthopedic implants and surgical equipment, neurotechnology and spine products, and medical and surgical equipment used in hospitals and other care settings. The company’s products also include patient-handling and emergency medical equipment, as well as instruments and technologies that support surgical procedures. Stryker serves healthcare customers in the United States and internationally.

About Merit Medical Systems

(Get Free Report)

Merit Medical Systems develops, manufactures and markets medical devices used in diagnostic and interventional procedures. Its products support clinicians in areas including cardiology, radiology, oncology and endoscopy. The company’s portfolio includes devices and accessories for vascular access, diagnostic and therapeutic procedures, drainage, biopsy and embolization. Merit serves hospitals, clinics and other healthcare providers through direct sales and distribution channels. Founded in 1987 and headquartered in South Jordan, Utah, Merit Medical serves customers in the United States and internationally.

Receive News & Ratings for Stryker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker and related companies with MarketBeat.com's FREE daily email newsletter.